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The reported incidence of SUDEP ranges from 0.7 to 1.3 cases per 1,000 patient-years in large cohorts of epilepsy patients 2, 3 and from 3.5 to 9.3 cases per 1,000 patient-years in antiepileptic drug registries, medical device registries, and epilepsy surgery programs. [4] [5] [6] SUDEP is currently accepted as the most important epilepsy-related mode of death 5, 7 and is associated with standardized mortality ratios in patients with ongoing seizures as high as 24 to 40 times those of the general population. 8 The exact mechanism or mechanisms leading to SUDEP remain unknown, 1, 5, 9, 10 and despite the identifi cation of several potential risk factors, elimination of seizures still represents the main intervention correlating with risk reduction. 5, 11 This review will fi rst discuss evidence for a cardiac mechanism of SUDEP, then review data traditionally used to support freedom from seizures following epilepsy surgery as a method for reducing SUDEP risk, and fi nally examine recent evidence suggesting that both SUDEP and seizure outcomes following epilepsy surgery are governed by a common pathway with certain cardiac manifestations.
  CENTRAL AUTONOMIC NETWORK
A tightly interconnected neuronal network controls various elements of the cardiovascular autonomic system. Consideration of a cardiac pathophysiology of SUDEP requires a fundamental understanding of this network (Figure 1) . 7, 12, 13 The insula, the anterior cingulate gyrus, and the ventromedial prefrontal cortex are key to central cortical control of autonomic function. The insula represents the primary viscerosensory cortex, whereas the cingulate gyrus and prefrontal cortices constitute the premotor autonomic region. At the subcortical level, the hypothalamus provides an interface with endocrine stimuli and triggers autonomic responses to maintain homeostasis. The amygdala, which is an integral component of the limbic system that links the previously mentioned cortical and subcortical centers, mediates the autonomic response to emotions. Beyond their centrality to autonomic control, the insula, amygdala, cingulate gyrus, and prefrontal cortex also represent the most common foci of partial epilepsy, a fi nding that might explain the frequent observation of autonomic changes in relation to epileptic seizures. 14 
  EVIDENCE FOR A CARDIAC MECHANISM OF SUDEP
The most signifi cant and broadly discussed cardiac mechanism of SUDEP is cardiac arrhythmia brought about by seizure discharges acting through the autonomic nervous system. 5, 7, 15, 16 Clinical evidence A wide spectrum of cardiac arrhythmias-from ictal asystole to atrial fi brillation to repolarization abnormalities to bundle branch blocks-has been reported during seizures. [14] [15] [16] [17] [18] [19] In one study, ictal cardiac arrhythmias occurred in 42% of hospitalized epilepsy patients, the most common being an irregular series of abrupt rate changes near the end of the electroencephalographic (EEG) seizure discharge. 17 In another study, R-R interval analysis dur-
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ing the fi rst 10-second period of EEG discharge showed a signifi cant early heart rate increase in 49% of seizures and an early heart rate reduction in 25.5%. 18 Certain clinical seizure characteristics have been correlated with the occurrence of ictal electrocardiographic (ECG) abnormalities. One study found that mean seizure duration was longer in patients with ECG abnormalities than in those without such changes. 16 Others observed that ictal ECG abnormalities occurred more often and were more severe in generalized tonic-clonic seizures than in complex partial seizures. 15, 16, 19 These same clinical seizure characteristics were correlated with a higher risk of SUDEP, 20 which suggests an interrelation among seizure semiology, ECG abnormalities, and SUDEP. The anterior cingulate and orbitofrontal cortex send projections to the hypothalamus and amygdala, but also to the autonomic centers within the brainstem: the periaqueductal gray matter, parabrachial nucleus, nucleus tractus solitarius, nucleus ambiguus, and rostral ventrolateral medulla. Parasympathetic infl uence on the heart arises primarily from the nucleus ambiguus. Sympathetic output receives tonic excitation from the ventrolateral medulla and projects from the intermediolateral cell columns to the cardiac conduction system and ventricle. Integrated response to emotion and stress (green arrows): The amygdala has reciprocal connections with the cerebral cortex and mediates autonomic response to emotions via projections to the hypothalamus and brainstem. The paraventricular nucleus of the hypothalamus controls internal homeostasis and innervates the autonomic relay centers in the rostral ventrolateral medulla, nucleus tractus solitarius, parabrachial nucleus, and preganglionic vagal and sympathetic neurons. Reprinted from Schuele et al, 12 which was modifi ed from Britton and Benarroch. 13 Additionally, direct evidence of seizure-related cardiac changes occurring specifi cally in SUDEP victims has come from a study that compared EEG and ECG data between 21 SUDEP patients and 43 clinically similar historical controls with refractory partial epilepsy. 15 The patients who eventually succumbed to SUDEP had a higher ictal maximal heart rate, a greater increase in heart rate with seizures arising from sleep, and a higher incidence of ictal cardiac repolarization and rhythm abnormalities.
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Experimental evidence Electrical brain stimulation of the limbic system and insular cortex has repeatedly been shown to provoke heart rate changes, including bradycardia, tachycardia, and asystole.
14 Some studies have even suggested a lateralized infl uence of the insulae on cardiovascular autonomic control, with intraoperative stimulation of the left posterior insula eliciting a cardioinhibitory response and hypotension, and with stimulation of the right anterior insula eliciting tachycardia and hypertension. 7 Other studies have suggested that the limbic system has a localization-related infl uence on cardiovascular responses, with stimulation of the amygdala alone being insuffi cient to produce the ictal tachycardia so commonly seen in epileptic seizures, which suggests that cortical involvement is essential for the increase in heart rate. 21 Such cortical stimulation-induced heart rate changes may explain how massive seizure-related discharges can affect cardiac rhythm during the seizure itself.
There is also, however, evidence of a baseline epilepsy-related autonomic dysfunction. Abnormalities in cardiac uptake of meta-iodobenzylguanidine (MIBG) have been demonstrated interictally in patients with chronic temporal lobe epilepsy relative to controls. 22 A recent study specifi cally showed a pronounced reduction in cardiac MIBG uptake in patients who had ictal asystole compared with other epileptic patients and nonepileptic controls, a fi nding that suggests a postganglionic cardiac catecholamine disturbance in patients with epilepsy. 23 The authors proposed that epilepsy-related impairment of sympathetic cardiac innervation limits adjustment and heart rate modulation, and may thus increase the risk of asystole and, ultimately, SUDEP. 23 
  EPILEPSY SURGERY AND SUDEP RISK
The above fi ndings make it reasonable to postulate that recurrent uncontrolled seizures may lead to signifi cant cardiac changes-namely, arrhythmias-which may then lead to a higher risk of SUDEP. Successful epilepsy surgery, the treatment of choice for uncontrolled partial epilepsy, would eliminate seizures and would thus be expected to reduce SUDEP risk.
Several studies support this hypothesis. Reductions in all-cause mortality and in SUDEP following successful epilepsy surgery have been observed when patients who became seizure-free after surgery were compared either with patients who had ongoing postoperative seizures or with patients with intractable epilepsy who did not undergo epilepsy surgery. 11, 24 In one study with a mean follow-up of 3.82 years, no deaths occurred among 199 patients who were seizure-free following epilepsy surgery, whereas there were 11 deaths-including 6 cases of SUDEP-among 194 patients who had persistent seizures following epilepsy surgery. 11 A separate study compared 202 patients who underwent epilepsy surgery with 46 patients with medically treated intractable epilepsy over a mean follow-up period of greater than 5.7 years. 24 In this study, death occurred in only 7% of the surgical patients compared with 20% of the medically treated patients, which suggests that epilepsy surgery (or lack thereof) may be an independent predictor of mortality. Favorable outcome was linked closely to seizure control, as 81% of the patients who died had 2 or more seizures per year at last follow-up, compared with only 47% of survivors in the overall cohort.
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Complete seizure resolution-not just reductionseems necessary for SUDEP risk reduction In our experience at the Cleveland Clinic Epilepsy Center, we have found that a reduction in seizure frequency following epilepsy surgery is not enough to eliminate SUDEP risk-complete freedom from seizures is required. Of 37 SUDEP cases identifi ed so far in a cohort of 3,481 patients evaluated in our epilepsy monitoring unit between 1990 and 2005 (Jehi et al, in preparation), 7 patients had undergone epilepsy surgery. None of these 7 patients was seizure-free at the time of death; four had a greater than 50% reduction in seizure frequency. No cases of SUDEP occurred in patients who were seizure-free after surgery.
Our fi ndings mirror earlier results reported by Sperling et al, 11 who also found that epilepsy surgery improves mortality only when seizures resolve completely, not when they merely "improve." It seems plausible, therefore, that elimination of seizures postoperatively eliminates the risk for the several seizure-related cardiac arrhythmogenic changes discussed above, thereby eliminating the risk for the series of events that eventually leads to SUDEP.
A role for stabilized baseline autonomic control?
Alternatively, some data suggest that the "autonomic" impacts of epilepsy surgery may extend beyond the immediate seizure-related manifestations to the baseline interictal period in epilepsy patients. One study found that surgery for temporal lobe epilepsy is followed by a reduction of sympathetic cardiovascular modulation and barorefl ex sensitivity. 25 The authors proposed that this fi nding may be attributable to decreased infl uences of interictal epileptogenic discharges on brain areas involved in cardiovascular autonomic control. These researchers continue to postulate that surgery for temporal lobe epilepsy seems to stabilize cardiovascular control in epilepsy patients by reducing the risk of sympathetically mediated tachyarrhythmias and excessive bradycardiac counterregulation, potentially lowering SUDEP risk. 25 
  CARDIAC FINDINGS, SUDEP, AND SEIZURE OUTCOMES
Whether it is the elimination of seizure-related cardiac arrhythmias achieved by rendering patients seizure-free after surgery, or whether it is the stabilization of baseline autonomic cardiac control by reducing interictal epileptiform discharges, this line of thought assumes that the autonomic dysfunction contributing to SUDEP is caused by epilepsy and that freedom from seizures following epilepsy surgery should therefore be responsible for reducing the risk of death. An alternative hypothesis for the infrequent occurrence of SUDEP in seizure-free patients may be that seizure outcomes following epilepsy surgery and SUDEP risk are actually both governed by the same underlying biologic process. This would suggest that the same patient cohort is at a higher baseline mortality risk and in a prognostically poorer seizure outcome group following epilepsy surgery.
This idea is supported by a recent prospective study among 21 consecutive candidates for temporal lobe epilepsy surgery in which spectral analysis of heart rate variability performed preoperatively was correlated with seizure control 1 year after surgery. 26 The study found that patients with poor seizure outcomes (Engel class II to IV, signifying ongoing postoperative seizures) had signifi cantly lower power in all domains of heart rate variability than did patients with favorable seizure outcomes. 26 In another study, heart rate was recorded in 16 patients before and after temporal lobe epilepsy surgery, and sympathetic and parasympathetic cardiac modulation was determined as powers of low-frequency (LF, 0.04-0.15 Hz) and high-frequency (HF, 0.15-0.5 Hz) heart rate oscillations. 27 The LF/HF ratio was calculated as an index of sympathovagal balance. Cardiac MIBG uptake was measured with MIBG single-photon emission computed tomography and compared with control data. Baseline sympathetic LF power and LF/HF ratio were higher in patients who eventually had persistent seizures than in those who became seizure-free. Following surgery, both measures decreased in seizure-free patients but increased in patients with persistent seizures. MIBG uptake was lower in patients than in controls and even lower yet in patients who had persistent seizures. In this subgroup, MIBG uptake declined further after surgery.
Essentially, both of the above studies 26, 27 demonstrate fi ndings of autonomic cardiac abnormalities that predated epilepsy surgery and reliably predicted the eventual surgical outcome in terms of seizure continuance. This suggests that "poor candidates" for epilepsy surgery-ie, those with lower chances of achieving seizure freedom with surgery-may a priori have a higher SUDEP risk. A possible explanation for these fi ndings may be epileptogenic zones, including the insula and other components of the central autonomic network, or molecular/genetic diffuse abnormalities that extend beyond a limited surgically removable seizure focus and involve the heart, increasing the risk for cardiac conduction abnormalities.
  CONCLUSIONS
SUDEP is the most common cause of death in epilepsy patients. A signifi cant body of literature suggests that a cardiac mechanism contributes to its occurrence. Although the exact relationship between seizure outcomes following epilepsy surgery and SUDEP risk is still being investigated, it is accepted that seizure control correlates with reduced mortality. Cardiac changes and autonomic dysregulation seem to be at the "heart" of the problem.
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